The program for the 14th WFH Global Forum will feature critical discussions on both access to therapies and emerging innovations. Among the highlights will be “Availability of Products” and “Gene Therapy & New Technology Access”—two sessions which will bring together experts to address some of the most pressing questions facing the global bleeding disorders community:
- How can we ensure sustainable and equitable access to current and future treatments?
- What is the potential of gene therapy and other new technologies?
- How can benefits and risks be balanced while advancing innovation and regional self-sufficiency?
Speakers such as Brian O’Mahony, Chief Executive, Irish Haemophilia Society; Radek Kaczmarek, Chair of the WFH Coagulation Product Safety, Supply and Access (CPSSA) Committee; and Glenn Pierce, MD, PhD, WFH Vice President, Medical; will share their perspectives and expertise at the forum. This unique event offers participants a rare opportunity to hear these world-renowned experts in conversation and actively join the debate.
With sessions designed to spark dialogue and meaningful exchange, the WFH Global Forum offers you a unique chance to engage with global leaders, share perspectives, and help shape the future of care for people with bleeding disorders.
To find out more about the 14th WFH Global Forum, click here.